Quantification of Neuroreceptors in the Living Human Brain. II. Inhibition Studies of Receptor Density and Affinity

[1]  A. Gjedde,et al.  Quantification of Neuroreceptors in the Living Human Brain. I. Irreversible Binding of Ligands , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  T Greitz,et al.  Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Alan A. Wilson,et al.  Dopamine and serotonin receptors measured in vivo in Huntington's Disease with C-11 n-methylspiperone PET imaging , 1985 .

[4]  D Comar,et al.  Kinetics and displacement of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography. , 1985, European journal of pharmacology.

[5]  C. D. Arnett,et al.  Comparison of Three 18F‐Labeled Butyrophenone Neuroleptic Drugs in the Baboon Using Positron Emission Tomography , 1985, Journal of neurochemistry.

[6]  Dean F. Wong,et al.  Imaging Opiate Receptors in the Human Brain by Positron Tomography , 1985, Journal of computer assisted tomography.

[7]  G. di Chiro,et al.  Atlas of Dopamine Receptor Images (PET) of the Human Brain , 1985, Journal of computer assisted tomography.

[8]  J. Links,et al.  Dopamine receptor binding of C-11-3-N-methylspiperone in the caudate in schizophrenia and bipolar disorder: a preliminary report. , 1985, Psychopharmacology bulletin.

[9]  M. Folstein,et al.  EFFECTS OF AGE ON DOPAMINE AND SEROTONIN RECEPTORS MEASURED BY POSITRON TOMOGRAPHY IN THE LIVING HUMAN BRAIN , 1984, Science.

[10]  P Riederer,et al.  Bimodal distribution of dopamine receptor densities in brains of schizophrenics. , 1984, Science.

[11]  M. Mintun,et al.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.

[12]  J. Links,et al.  An anatomically realistic brain phantom for quantification with positron tomography , 1984 .

[13]  J. Links,et al.  Imaging dopamine receptors in the human brain by positron tomography. , 1984, Science.

[14]  M. Mintun,et al.  Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: potential agents for imaging the dopamine receptor. , 1983, Life sciences.

[15]  Jonathan M. Links,et al.  Imaging dopamine receptors in the human brain by positron tomography , 1983 .

[16]  J C Mazziotta,et al.  Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical Effects , 1981, Journal of computer assisted tomography.

[17]  P. Seeman.  Brain dopamine receptors. , 1980, Pharmacological reviews.

[18]  M. Raichle,et al.  Preliminary studies with [18F]haloperidol: a radioligand for in vivo studies of the dopamine receptors , 1980, Brain Research.

[19]  J. Leysen,et al.  Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding. , 1978, Biochemical pharmacology.

[20]  M. Kuhar,et al.  Dopamine receptor binding in vivo: the feasibility of autoradiographic studies. , 1978, Life sciences.